Tesu Saglik Teknolojileri A.S. (“Tesu Health“) has been chosen as one of the ten companies worldwide to participate in the prestigious Cambridge Life Sciences Market Access Programme, administered by Locate Cambridge. This remarkable achievement positions Tesu Health as a frontrunner in the rapidly evolving landscape of life sciences and underscores the region’s pivotal role as a gateway to the UK market.
Share this article
Locate Cambridge, the representative body for the combined authority of Cambridge, Peterborough, and Fenland, has meticulously selected Tesu Health and nine other innovative companies from across the globe to receive VIP support in establishing their presence in the Cambridge and Peterborough region.
The Cambridge and Peterborough region is renowned for its world-class research institutions, a diverse talent pool, cutting-edge innovation, and an ecosystem rich in business support and investment opportunities.
Tesu Health, with its commitment to improving global healthcare through technological advancements, is set to benefit significantly from this unparalleled opportunity. The company’s innovative solutions align perfectly with the region’s life sciences ecosystem, positioning Tesu Health to make a lasting impact on healthcare worldwide.
The Cambridge Life Sciences Market Access Programme provides Tesu Health with a unique platform to access resources, forge strategic partnerships, and tap into investment funds essential for scaling its operations.
Tesu Health’s selection for this program reaffirms the company’s dedication to transforming healthcare and improving patient outcomes. As Tesu Health embarks on this exciting journey in the heart of the UK’s life sciences hub, the company aims to leverage the region’s resources to accelerate its mission of making high-quality healthcare accessible to all.